This study aims to evaluate the effect of PAI-1 on PD-L1 expression in tumor cells and elucidate the underlying mechanisms of tumorigenesis, thereby defining PAI-1 as a molecular target for cancer therapy. The gene discussed is CD274; the disease is neoplasm.